fda glp-1 warning news november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Myths & Facts: GLP-1 Drugs

The risk of cardiovascular disease increases by three to six-fold with the coexistence of diabetes and hypertension

Retatrutide cannot be compounded at all because it is an investigational drug

Investigation of the relationship between apolipoprotein E alleles and serum lipids in Alzheimers disease: a meta-analysis

Improved 6MWD also correlates with better quality of life and lower HF hospitalization risk in HFpEF, which reinforces the therapeutic potential of GLP-1RAs beyond metabolic control

[DOI] [PubMed] [Google Scholar] 78.Cheng YH, Ho MS, Huang WT, Chou YT, King K

M.Funcasta-CalderonR.Fernandez-FernandezC.Castro-QuintelaE.Carneiro-FreireN